These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9004081)

  • 1. Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours.
    London CA; Kisseberth WC; Galli SJ; Geissler EN; Helfand SC
    J Comp Pathol; 1996 Nov; 115(4):399-414. PubMed ID: 9004081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine mast cell tumors express stem cell factor receptor.
    Reguera MJ; Rabanal RM; Puigdemont A; Ferrer L
    Am J Dermatopathol; 2000 Feb; 22(1):49-54. PubMed ID: 10698217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit.
    London CA; Galli SJ; Yuuki T; Hu ZQ; Helfand SC; Geissler EN
    Exp Hematol; 1999 Apr; 27(4):689-97. PubMed ID: 10210327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms.
    Ma Y; Longley BJ; Wang X; Blount JL; Langley K; Caughey GH
    J Invest Dermatol; 1999 Feb; 112(2):165-70. PubMed ID: 9989791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
    Meyer A; Gruber AD; Klopfleisch R
    J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
    Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
    J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
    Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
    J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tandem duplication of KIT exon 11 influences the proteome of canine mast cell tumours.
    Schlieben P; Meyer A; Weise C; Bondzio A; Gruber AD; Klopfleisch R
    J Comp Pathol; 2013 May; 148(4):318-22. PubMed ID: 22935087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine.
    Thamm DH; Weishaar KM; Charles JB; Ehrhart EJ
    Vet Comp Oncol; 2020 Jun; 18(2):169-175. PubMed ID: 31365175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
    Preziosi R; Morini M; Sarli G
    J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells and canine mast cell tumours. A review.
    Misdorp W
    Vet Q; 2004 Dec; 26(4):156-69. PubMed ID: 15663212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells.
    Tsai M; Chen RH; Tam SY; Blenis J; Galli SJ
    Eur J Immunol; 1993 Dec; 23(12):3286-91. PubMed ID: 7504992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
    Fröberg GK; Lindberg R; Ritter M; Nordlind K
    J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines.
    Takeuchi Y; Fujino Y; Watanabe M; Nakagawa T; Ohno K; Sasaki N; Sugano S; Tsujimoto H
    Vet Immunol Immunopathol; 2010 Oct; 137(3-4):208-16. PubMed ID: 20591500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
    Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
    Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells.
    Ishizuka T; Chayama K; Takeda K; Hamelmann E; Terada N; Keller GM; Johnson GL; Gelfand EW
    J Immunol; 1999 Feb; 162(4):2087-94. PubMed ID: 9973482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-kit and stem cell factor mRNA in liver specimens from healthy adult dogs.
    Morimoto M; Tsujimura T; Kanakura Y; Kitamura Y; Matsuda H
    Am J Vet Res; 1998 Mar; 59(3):363-6. PubMed ID: 9522959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
    Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
    BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent gene mutations detected in canine mast cell tumours by next generation sequencing.
    Vozdova M; Kubickova S; Pal K; Fröhlich J; Fictum P; Rubes J
    Vet Comp Oncol; 2020 Dec; 18(4):509-518. PubMed ID: 31999054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of molecular genetic contributants to canine cutaneous mast cell tumour metastasis by global gene expression analysis.
    Bowlt Blacklock K; Birand Z; Biasoli D; Fineberg E; Murphy S; Flack D; Bass J; Di Palma S; Blackwood L; McKay J; Whitbread T; Fox R; Eve T; Beaver S; Starkey M
    PLoS One; 2018; 13(12):e0208026. PubMed ID: 30566430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.